{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:43:25Z","timestamp":1792878205530,"version":"4.5.0"},"reference-count":70,"publisher":"European Respiratory Society (ERS)","issue":"155","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,2,7]]},"published-print":{"date-parts":[[2020,3,31]]},"abstract":"<jats:p>Pulmonary sarcoidosis presents substantial management challenges, with limited evidence on effective therapies and phenotypes. In the absence of definitive evidence, expert consensus can supply clinically useful guidance in medicine. An international panel of 26 experts participated in a Delphi process to identify consensus on pharmacological management in sarcoidosis with the development of preliminary recommendations.<\/jats:p>\n                  <jats:p>The modified Delphi process used three rounds. The first round focused on qualitative data collection with open-ended questions to ensure comprehensive inclusion of expert concepts. Rounds 2 and 3 applied quantitative assessments using an 11-point Likert scale to identify consensus.<\/jats:p>\n                  <jats:p>Key consensus points included glucocorticoids as initial therapy for most patients, with non-biologics (immunomodulators), usually methotrexate, considered in severe or extrapulmonary disease requiring prolonged treatment, or as a steroid-sparing intervention in cases with high risk of steroid toxicity. Biologic therapies might be considered as additive therapy if non-biologics are insufficiently effective or are not tolerated with initial biologic therapy, usually with a tumour necrosis factor-\u03b1 inhibitor, typically infliximab.<\/jats:p>\n                  <jats:p>The Delphi methodology provided a platform to gain potentially valuable insight and interim guidance while awaiting evidenced-based contributions.<\/jats:p>","DOI":"10.1183\/16000617.0146-2019","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T12:05:23Z","timestamp":1584705923000},"page":"190146","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":146,"title":["Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis"],"prefix":"10.1183","volume":"29","author":[{"given":"Franck F.","family":"Rahaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-0221","authenticated-orcid":false,"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Barney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S.","family":"Birring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Costabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott D.","family":"Crouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Drent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Gerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel Y.","family":"Hamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isham","family":"Huizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"W.","family":"Ennis James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-9828","authenticated-orcid":false,"given":"Huiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mirsaeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"M\u00fcller-Quernheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Carmona Porquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobelia","family":"Samavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Scholand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"2024102403441550000_29.155.190146.1","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.84"},{"key":"2024102403441550000_29.155.190146.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0013-2016"},{"key":"2024102403441550000_29.155.190146.3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-46"},{"key":"2024102403441550000_29.155.190146.4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"2024102403441550000_29.155.190146.5","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"2024102403441550000_29.155.190146.6","doi-asserted-by":"crossref","first-page":"e0176859","DOI":"10.1371\/journal.pone.0176859","article-title":"Sarcoidosis in an Italian province. Prevalence and environmental risk factors","volume":"12","author":"Beghe","year":"2017","journal-title":"PLoS One"},{"key":"2024102403441550000_29.155.190146.7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ijd.12633","article-title":"Epidemiology of sarcoidosis in Afro-Caribbean people: a 7-year retrospective study in Guadeloupe","volume":"54","author":"Coquart","year":"2015","journal-title":"Int J Dermatol"},{"key":"2024102403441550000_29.155.190146.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02419-2016"},{"key":"2024102403441550000_29.155.190146.9","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201508-568BC"},{"key":"2024102403441550000_29.155.190146.10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00408-016-9952-6","article-title":"Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976\u20132013","volume":"195","author":"Ungprasert","year":"2017","journal-title":"Lung"},{"key":"2024102403441550000_29.155.190146.11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1346-8138.13654","article-title":"Comorbid autoimmune diseases in patients with sarcoidosis: a nationwide case-control study in Taiwan","volume":"44","author":"Wu","year":"2017","journal-title":"J Dermatol"},{"key":"2024102403441550000_29.155.190146.12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/resp.13105","article-title":"Resolution rate of pulmonary sarcoidosis and its related factors in a Japanese population","volume":"22","author":"Hattori","year":"2017","journal-title":"Respirology"},{"key":"2024102403441550000_29.155.190146.13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/1744666X.2016.1175301","article-title":"Biologic therapies in the treatment of sarcoidosis","volume":"12","author":"Saketkoo","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"2024102403441550000_29.155.190146.14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCP.0000000000000080","article-title":"Morbidity and mortality in sarcoidosis","volume":"20","author":"Gerke","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"2024102403441550000_29.155.190146.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00224513"},{"key":"2024102403441550000_29.155.190146.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00060612"},{"key":"2024102403441550000_29.155.190146.17","first-page":"CD001114","article-title":"Corticosteroids for pulmonary sarcoidosis","volume":"2","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102403441550000_29.155.190146.18","first-page":"CD003536","article-title":"Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis","volume":"3","author":"Paramothayan","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102403441550000_29.155.190146.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(08)70002-7"},{"key":"2024102403441550000_29.155.190146.20","first-page":"1543","article-title":"Domains of quality of life: results of a three-stage Delphi consensus procedure among patients, family of patients, clinicians, scientists and the general public","volume":"23","author":"Pietersma","year":"2014","journal-title":"Qual Life Res"},{"key":"2024102403441550000_29.155.190146.21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6920-13-9","article-title":"Protocol for development of the guideline for reporting evidence based practice educational interventions and teaching (GREET) statement","volume":"13","author":"Phillips","year":"2013","journal-title":"BMC Med Educ"},{"key":"2024102403441550000_29.155.190146.22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1472-6920-14-159","article-title":"A Delphi survey to determine how educational interventions for evidence-based practice should be reported: stage 2 of the development of a reporting guideline","volume":"14","author":"Phillips","year":"2014","journal-title":"BMC Med Educ"},{"key":"2024102403441550000_29.155.190146.23","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp14X681001"},{"key":"2024102403441550000_29.155.190146.24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-268"},{"key":"2024102403441550000_29.155.190146.25","first-page":"44","article-title":"Development of a physical performance assessment checklist for athletes who sustained a lower extremity injury in preparation for return to sport: a Delphi study","volume":"8","author":"Haines","year":"2013","journal-title":"Int J Sports Phys Ther"},{"key":"2024102403441550000_29.155.190146.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.23718"},{"key":"2024102403441550000_29.155.190146.27","first-page":"S47","article-title":"Interactions between rheumatologists and cardio-\/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis","volume":"28","author":"Huscher","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2024102403441550000_29.155.190146.28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","article-title":"Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials","volume":"69","author":"Saketkoo","year":"2014","journal-title":"Thorax"},{"key":"2024102403441550000_29.155.190146.29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/690109","article-title":"Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation","volume":"7","author":"Rahaghi","year":"2017","journal-title":"Pulm Circ"},{"key":"2024102403441550000_29.155.190146.30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2045893217721695","article-title":"Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): a Delphi consensus document","volume":"7","author":"Rahaghi","year":"2017","journal-title":"Pulm Circ"},{"key":"2024102403441550000_29.155.190146.31","first-page":"149","article-title":"American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441550000_29.155.190146.32","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3181b97635"},{"key":"2024102403441550000_29.155.190146.33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/17512433.2018.1486706","article-title":"Treatment of sarcoidosis: grading the evidence","volume":"11","author":"James","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2024102403441550000_29.155.190146.34","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl038"},{"key":"2024102403441550000_29.155.190146.35","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.149.4.8143052"},{"key":"2024102403441550000_29.155.190146.36","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.3.238"},{"key":"2024102403441550000_29.155.190146.37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.2.424"},{"key":"2024102403441550000_29.155.190146.38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.1.24"},{"key":"2024102403441550000_29.155.190146.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)90493-X"},{"key":"2024102403441550000_29.155.190146.40","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199903000-00001"},{"key":"2024102403441550000_29.155.190146.41","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00156314"},{"key":"2024102403441550000_29.155.190146.42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-2600(15)00199-X","article-title":"New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches","volume":"3","author":"Baughman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102403441550000_29.155.190146.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.12.009"},{"key":"2024102403441550000_29.155.190146.44","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","article-title":"No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis","volume":"138S","author":"Broos","year":"2018","journal-title":"Respir Med"},{"key":"2024102403441550000_29.155.190146.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.09.003"},{"key":"2024102403441550000_29.155.190146.46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"key":"2024102403441550000_29.155.190146.47","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441550000_29.155.190146.48","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430080088011"},{"key":"2024102403441550000_29.155.190146.49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003431"},{"key":"2024102403441550000_29.155.190146.50","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1728"},{"key":"2024102403441550000_29.155.190146.51","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283642a7a"},{"key":"2024102403441550000_29.155.190146.52","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441550000_29.155.190146.53","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-402OC"},{"key":"2024102403441550000_29.155.190146.54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2024102403441550000_29.155.190146.55","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology"},{"key":"2024102403441550000_29.155.190146.56","first-page":"289","article-title":"Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial","volume":"32","author":"Baughman","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441550000_29.155.190146.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.04.011"},{"key":"2024102403441550000_29.155.190146.58","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441550000_29.155.190146.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.056"},{"key":"2024102403441550000_29.155.190146.60","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.1062"},{"key":"2024102403441550000_29.155.190146.61","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.177"},{"key":"2024102403441550000_29.155.190146.62","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00000914"},{"key":"2024102403441550000_29.155.190146.63","doi-asserted-by":"crossref","first-page":"1756286418805732","DOI":"10.1177\/1756286418805732","article-title":"Successful therapy with rituximab in three patients with probable neurosarcoidosis","volume":"11","author":"Zella","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"2024102403441550000_29.155.190146.64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"2024102403441550000_29.155.190146.65","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1044"},{"key":"2024102403441550000_29.155.190146.66","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci073"},{"key":"2024102403441550000_29.155.190146.67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2014.10.006","article-title":"The spectrum of opportunistic diseases complicating sarcoidosis","volume":"14","author":"Jamilloux","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2024102403441550000_29.155.190146.68","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2003.02537.x"},{"key":"2024102403441550000_29.155.190146.69","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2000.01567.x"},{"key":"2024102403441550000_29.155.190146.70","first-page":"1","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract Assess Res Eval"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0146-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:01:31Z","timestamp":1740355291000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0146-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":70,"journal-issue":{"issue":"155","published-online":{"date-parts":[[2020,3,20]]},"published-print":{"date-parts":[[2020,3,31]]}},"alternative-id":["10.1183\/16000617.0146-2019"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0146-2019","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}